Determination of HCV genotype by direct sequence analysis of quantitative PCR products. 2003

Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
Laboratory of Virology, Spedali Civili, Brescia, Italy. gargiulo@bshosp.osp.unibs.it

Hepatitis C virus (HCV) genotyping, combined with quantitative evaluation of HCV RNA, may be beneficial for the management of chronic hepatitis C and in the selection of candidates for interferon treatment. In this study, the COBAS AMPLICOR HCV MONITOR test, a commercially available quantitative assay for HCV RNA, was used. Amplification products obtained from HCV-positive cases were subjected to direct sequencing and genotyping based on seven phylogenetically informative regions within the 5'UTR. Results were compared with those obtained by INNO-LiPA assay. Typing results yielded by both methods were in complete accordance for type and subtype assignment. Twenty-nine of 500 specimens (5.8%) were unclassifiable and belonged to samples with a titer of <70.000 IU, as determined by quantitative assay. Despite this limitation, the overall gain in efficiency, the low rate of test failure and a better resolution of mixed genotypes all constitute a considerable advantage of this system over the commercial hybridization technique for routine clinical laboratory use.

UI MeSH Term Description Entries
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C
D020121 5' Untranslated Regions The sequence at the 5' end of the messenger RNA that does not code for product. This sequence contains the ribosome binding site and other transcription and translation regulating sequences. 5'UTR,Leader Sequences, mRNA,Leader mRNA Sequences,mRNA Leader Sequences,5' UTR,5' UTRs,5' Untranslated Region,5'UTRs,Leader Sequence, mRNA,Leader mRNA Sequence,Region, 5' Untranslated,Regions, 5' Untranslated,Sequence, Leader mRNA,Sequence, mRNA Leader,Sequences, Leader mRNA,Sequences, mRNA Leader,UTR, 5',UTRs, 5',Untranslated Region, 5',Untranslated Regions, 5',mRNA Leader Sequence,mRNA Sequence, Leader,mRNA Sequences, Leader

Related Publications

Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
August 1999, Journal of clinical microbiology,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
December 1997, Journal of virological methods,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
March 1993, Nihon Rai Gakkai zasshi,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
April 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
August 1991, BioTechniques,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
March 2008, The Journal of hospital infection,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
March 2018, Drug metabolism and personalized therapy,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
February 2008, Journal of microbiology (Seoul, Korea),
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
April 2018, Journal of chromatography. A,
Franco Gargiulo, and Maria Antonia De Francesco, and Gabriele Pinsi, and Caterina Pollara, and Luigina Terlenghi, and Francesca Perandin, and Nino Manca
September 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!